UBS Assumes Inspire Medical Systems at Sell, Lowers Price Target of $39
Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. INSP | 0.00 |
UBS analyst Patrick Wood assumes Inspire Medical Systems (NYSE:
INSP) with a Sell rating and lowers Price Target of $39.